SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (6830)7/30/2002 2:41:08 PM
From: Sam Citron  Read Replies (1) | Respond to of 52153
 
Peter,

I notice that SEPR has recently dropped on the "favorite stocks" section of your SI profile from #1 AND #2 to #3. Can you please explain what, if any, significance to attach to this change and whether you still regard SEPR as a LT buy or as a hopelessly broken stock.

Sam



To: Biomaven who wrote (6830)7/30/2002 2:55:46 PM
From: rkrw  Read Replies (1) | Respond to of 52153
 
Point well taken, but it's unlikely they even approach that kind of net effect.

As of the latest proxy (exercisable and unexercisable options):

Timothy J. Barberich 1,236,346 624,834
William J. O'Shea 236,666 775,834
David P. Southwell 318,000 412,500
Paul D. Rubin, M.D. 333,334 493,334
Robert F. Scumaci 133,667 355,667

Can't say I feel sorry for these guys.



To: Biomaven who wrote (6830)7/30/2002 4:13:34 PM
From: Ian@SI  Read Replies (2) | Respond to of 52153
 
...what I call revolving door repricing.

Not quite the same thing. Options issued to the departing executive will expire worthless rather than being returned to the treasury. The new guy gets new options reducing the total amount available for issue.

It's unlikely that shareholders will approve any new allotments any time soon.

I also think that repricing should be banned. ...until the company is willing to reimburse me for any loss I took as an owner of their company by buying too soon.

To the extent that they have the shareholders' blessing they can always issue new options any time they so choose.



To: Biomaven who wrote (6830)7/30/2002 9:20:10 PM
From: Madharry  Respond to of 52153
 
And what is wrong with that Peter? At least it allows the company to hopefully upgrade its personnel. I think repricing of existing options should not be permitted until specifically approved by shareholder vote. otherwise it just amounts to employee theft. .